Particle.news

Download on the App Store

Rush University Medical Center Pauses Hormonal Treatments for Under-18 Patients

The pause effective July 1 aligns with a Trump administration order that threatens to cut research grants for hospitals providing gender-affirming care to minors.

Rush University Medical Center on Sept. 13, 2022. (Antonio Perez/Chicago Tribune)
Image

Overview

  • Rush stopped offering puberty blockers and hormone replacement therapy to new patients under 18 as of July 1.
  • Current minor patients may remain on hormonal treatments only if discontinuing would pose potential harm.
  • The system continues to provide mental health, behavioral health and social services to gender care patients of all ages.
  • Other Chicago providers like Lurie Children’s and UI Health have similarly scaled back youth gender-affirming services under federal funding pressure.
  • Families and state attorneys general have filed lawsuits and the U.S. Department of Justice has subpoenaed patient records from youth gender-affirming care providers.